Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
dirucotide (4 trials)
Multiple Sclerosis (Phase 3)
Multiple Sclerosis, Chronic Progressive (Phase 3)
Multiple Sclerosis, Relapsing-Remitting (Phase 3)
Neoplasm Metastasis (Phase 3)
Sclerosis (Phase 3)
Trials (4 total)
Trial APIs (1 total)